Please do not fill-in this field

About
Our Work
Services & Facilities
People
Education
Careers
News & Events

Support Our Work

Please do not fill-in this field

A joint venture between The University of Melbourne and The Royal Melbourne Hospital

Please do not fill-in this field

About
Our Work
- Institute Themes
- Immunology
- Antimicrobial Resistance and Healthcare Associated Infections
Services & Facilities
- Services
- Facilities
People
Education
Careers
News & Events

Support Our Work

News & Events

News

29 May 2017

Cold and flu start-up Innavac receives AU$6.3 million in venture capital
11 May 2017

Immunologist named Howard Hughes Medical Institute (HHMI) – Gates International Research Scholar
09 May 2017

The flu-hunters at the Doherty Institute
02 May 2017

Doherty Institute scientist acknowledged for work with Indian collaborators

News Archive

2018
- January
- February
- March
- April
- May
- June
- July
- August
- September
2017
- January
- February
- March
- April
- May
- June
- July
- August
- September
- October
- November
- December
2016
- January
- February
- March
- April
- May
- June
- July
- August
- September
- October
- November
- December
2015
- June
- July
- August
- October
- November
- December

KEEP INFORMED

Facebook
Twitter
Instagram

Subscribe for the latest news, events and research

For any media enquiries, please contact:

Catherine Somerville
Senior Media and Communications Officer
T: +61 (0) 3 8344 8378
E: [email protected]

Rebecca Elliott
Communications Manager
T: +61 (0) 3 8344 8360
E: [email protected]

Contact Us

792 Elizabeth Street
Melbourne, 3000
Get Directions

[email protected]
+61 3 9035 3555
Contact Us

Keep informed

Facebook
Twitter
Instagram
LinkedIn

Subscribe for the latest news, events and research

We acknowledge the Wurundjeri people of the Kulin Nation as the traditional custodians of the land where our Institute stands.

We are committed to collaboration with Aboriginal and Torres Strait Islander communities to reduce the unacceptable burden of infectious disease. We are committed to training the next generation of exceptional Indigenous leaders in infection and immunity.